🔗 Share this article

As the US undertakes historic revisions to its vaccination guidelines, a particular individual has emerged in a surprising turn: Høeg, a Danish American sports physician and public health researcher who initially gained attention by expressing skepticism about coronavirus shots throughout the pandemic and has concentrated on possible fatalities after Covid vaccination in her recent time at the FDA.

Scheduled Overhauls to Childhood Immunization Program

Health officials were set to announce major revisions to the childhood vaccination calendar in December, synchronizing the US with the Danish national calendar, sources say – a substantial departure that would place the US out of step with a large portion of the world with insufficient data for improved outcomes. The planned update has been pushed back until the coming year.

Rather than the director of the vaccine center, Tracy Beth Høeg is set to speak at the event. She was recently named interim head of the FDA’s Center for Drug Evaluation and Research (CDER), the fifth person to head the division this calendar year.

A New Direction at the Agency

This interim role might represent a strengthened alliance between the drug and biologics centers as Høeg and Prasad consolidate power at the regulatory agency – and it signals a increased emphasis upon reevaluating long-standing vaccines at the FDA.

The new acting director has often pushed for halting certain childhood immunization guidelines in the US so as to align more similar to Denmark, a nation with universal health coverage and a population approximately the size of the state of Wisconsin.

To date public appearances, she has persisted in emphasizing on vaccines – usually the responsibility of Dr. Prasad, director of the FDA’s vaccine center – rather than pharmaceutical oversight.

Questions Over Background

Høeg has little discernible experience in drug development, regulation or administrative roles, which has been standard for past heads of the Center for Biologics Evaluation and Research. She has worked at the FDA as a top consultant to the agency head and the vaccine center since March.

“She appears not to have the requisite experience” for running the CDER, remarked a neurologist and psychiatrist. “She’s never run a scientific study. She has no expertise in managing a sizeable institution. She is not an expert in industry regulation.”

Past commissioners of CBER would “be deeply familiar with legal statutes and the underlying principles of pharmaceutical innovation”, commented Dr. Janet Woodcock. “Clearly, she doesn’t have the type of experience that former directors who led the center have had.”

This division has an enormous portfolio at the agency, she emphasized.

“The public just pays attention on the new drug program, but the off-patent medication office approves a multitude of off-brand pharmaceuticals. There is also a biosimilars program, over-the-counter program and so forth, and all of those must be supervised,” she said. “The responsibility you neglect, that is the part that I always told people is going to come back to haunt you.”

Furthermore, a major leadership aspect to the job, which supervises in excess of 5,000 personnel. “It’s a huge management job, if you do it right,” she said.

Agency Reaction and Disputed Initiatives

When asked about questions about Dr. Høeg's qualifications and whether this appointment signifies increased cooperation among FDA leaders on vaccines, a representative stated that the “questions rely on flawed premises”.

“Her resume is consistent with the functions of her job,” the representative explained, noting the months Dr. Høeg spent advising the FDA commissioner on “medication safety and regulatory science, including computational safety modeling and immunization monitoring”.

As acting director, Dr. Høeg assumes responsibility for the agency head's controversial expedited review system, a contentious one-day therapy clearance system that apparently troubled her former heads. “By what process are these medications being picked for this voucher program? Who is making the calls?” Dr. Howard said. “There’s a lot of secrecy occurring at the FDA right now.”

In general, he said, “the agency appears to be shifting towards less stringent rules of all drugs, with the exception of immunizations.”

Documented History on Immunizations

Regarding vaccines, Dr. Høeg has a more documented, if concerning, history, some experts observe. She released a research paper using unconfirmed public submissions to estimate the rate of myocarditis following COVID-19 vaccination. She consulted for the Florida chief medical officer Joseph Ladapo, who allegedly have modified findings to imply COVID-19 vaccines are more dangerous than they are.

Part of her “desired changes” for the current government encompassed revising rules for recently developed shots and discontinuing “non-essential” vaccines, she remarked post-election on a audio program. At the FDA, Dr. Høeg has allegedly proposed excluding teenage boys from obtaining Covid vaccinations.

“She is an all-around true believer who begins with her conclusions and tailors the evidence to accommodate the evidence in a very misleading, dishonest manner,” Dr. Howard argued.

Taking Control and a “Campaign of Retribution”

Høeg joined fellow dissenters, {like|